Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...
Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...
Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
o Henrik Møller<br />
King's College London, UK<br />
Intensity of radical resection for lung cancer in relation to survival<br />
outcomes in England<br />
o Alex Chacko<br />
Queen’s University Belfast, UK<br />
The mitochondrial ATP transporter VDAC1 /Porin is required for<br />
TRAIL-induced apoptosis in non-small cell lung cancer<br />
New strategies for improving prognosis in breast cancer<br />
Hosted by Ian Smith<br />
The Institute of <strong>Cancer</strong> Research and Royal Marsden Hospital, Sutton, UK<br />
o Ian Smith<br />
The Institute of <strong>Cancer</strong> Research and Royal Marsden Hospital, Sutton, UK<br />
Introduction<br />
o John Robertson<br />
University of Nottingham, UK<br />
Auto-antibodies in breast cancer: a new diagnostic tool?<br />
o Stephen Johnston<br />
The Institute of <strong>Cancer</strong> Research and Royal Marsden Hospital, Sutton, UK<br />
Combined targeted therapies in breast cancer<br />
o Robert Coleman<br />
Weston Park Hospital, University of Sheffield, UK<br />
Bone targeted therapy: modifying the soil to prevent metastatic<br />
seeding<br />
Proffered paper presentations:<br />
o Jason S Carroll<br />
University <strong>Cancer</strong> Research UK; Cambridge Research Institute, Cambridge,<br />
UK<br />
BACR/AstraZeneca Frank Rose Young Scientist Award<br />
Understanding how pioneer factors regulate Oestrogen receptor<br />
function in breast cancer cells<br />
o<br />
Darran O’Connor<br />
University College Dublin, Ireland<br />
The cocaine and amphetamine-regulated transcript (CART) is an<br />
independent prognostic factor in lymph node-negative breast<br />
cancer and predicts tamoxifen response<br />
o Neil Jelly<br />
University of Lincoln, UK<br />
Anti-stem cell factor enhances the effect of Anthracycline and<br />
Taxane chemotherapy in chemoresistant breast cancer cell<br />
lines<br />
15